CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma
CD19 和 CD30 CAR T 细胞免疫疗法治疗高危经典型霍奇金淋巴瘤
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2020.607362
Xue, YuanBo; Lai, Xun; Li, RuiLei; Ge, ChunLei; Zeng, BaoZhen; Li, Zhen; Fu, QiaoFen; Zhao, LiuFang; Dong, SuWei; Yang, JinYan; Guo, JiYin; Meng, QingYin; Tan, QingHua; Li, ZhenHui; Ding, HaiYan; Zhang, YanLei; Liu, ShaoHui; Chang, Alex H; Yao, Hong; Luo, RongCheng
T细胞
淋巴瘤
CD30
CD3
细胞生物学
CD19
免疫/内分泌
